Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biofrontera (BFRI) Tax Provisions (2020 - 2025)

Biofrontera has reported Tax Provisions over the past 6 years, most recently at $6000.0 for Q3 2025.

  • For Q3 2025, Tax Provisions rose 100.0% year-over-year to $6000.0; the TTM value through Dec 2025 reached $26000.0, up 23.81%, while the annual FY2025 figure was $25000.0, 13.64% up from the prior year.
  • Tax Provisions for Q3 2025 was $6000.0 at Biofrontera, down from $21000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $44000.0 in Q2 2021 and troughed at -$6000.0 in Q4 2023.
  • A 5-year average of $8277.8 and a median of $4000.0 in 2021 define the central range for Tax Provisions.
  • Biggest five-year swings in Tax Provisions: soared 2900.0% in 2022 and later tumbled 700.0% in 2023.
  • Year by year, Tax Provisions stood at $5000.0 in 2021, then plummeted by 80.0% to $1000.0 in 2022, then tumbled by 700.0% to -$6000.0 in 2023, then skyrocketed by 50.0% to -$3000.0 in 2024, then skyrocketed by 300.0% to $6000.0 in 2025.
  • Business Quant data shows Tax Provisions for BFRI at $6000.0 in Q3 2025, $21000.0 in Q2 2025, and -$1000.0 in Q1 2025.